Judge Orders FDA to Begin Limiting Antibiotics on Farms

|

The FDA has been ordered to resume efforts first initiated 35 years ago, which would limit the use of certain antibiotics on farms that may be contributing to increasing problems with antibiotic-resistent infections suffered by humans. 

United States Magistrate Judge Theodore Katz ruled last week in New York that the FDA must begin the process of eliminating the non-medical use of penicillin and tetracycline antibiotics on livestock.

The drugs are given in low doses to cattle, pigs, chickens and turkeys to promote growth and to work as a prophylactic against disease and illness. However, the use of the antibiotics for non-therapeutic reasons has been known to be unsafe to humans for decades, because they promote the creation of antibiotic resistant bacteria, so-called superbugs.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Although the FDA first indicated that it would start limiting use of such non-medical uses in 1977, the agency has failed to take corrective action against the livestock industry, prompting a lawsuit by the environmental and consumer watchdog groups, the National Resource Defense Council, Public Citizen, the Center for Science in the Public Interest, the Food Animal Concerns Trust and the Union of Concerned Scientists.

Drug makers may now be required to petition the FDA for approval of any antibiotic slated for animal use and must prove that the drugs are safe for human health.

Some groups estimate that about 70% of all antibiotics used in the United States are given to farm animals at low doses. Critics say that the antibiotics are used to compensate for unsanitary and inhumane treatment at animal feedlots and to speed up growth to make them fatter and get them to market faster. The levels given to the animals are too low to actually treat diseases.

For years, scientists have warned that the practice was promoting the growth of antibiotic-resistant bacteria which could jump species from livestock to humans. The number of such “superbugs.” like methicillin-resistant Staphylococcus aureus bacteria (MRSA), have increased in recent years.

MRSA infections, have accounted for more than 60 percent of hospital staph infections in recent years. The CDC reports that about 126,000 hospital MRSA infections occur each year, resulting in about 5,000 deaths. But some researchers suggest that the number of deaths from MRSA in the U.S. is closer to 20,000 annually.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients.
A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised.